Axitinib

Name: Axitinib
Brand: Selleck Chemicals
SKU: S1005
Rating: 5 (100 reviews)

For research use only.

Licensed by Pfizer Catalog No.S1005 Synonyms: AG 013736

100 publications

CAS No. 319460-85-0

Axitinib (AG 013736) is a multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ and c-Kit with IC50 of 0.1 nM, 0.2 nM, 0.1-0.3 nM, 1.6 nM and 1.7 nM in Porcine aorta endothelial cells, respectively.

Selleck's Axitinib has been cited by 100 publications

Cell, 2018, 173(1):74-89

PubMed: 29570999 ( click the link to review the publication )

Cell, 2018, 173(1):117-129

PubMed: 29570992 ( click the link to review the publication )

Cancer Discov, 2012, 2(4):344-55

PubMed: 22576211 ( click the link to review the publication )

Hum Mol Genet, 2021, ddab011

PubMed: 33438013 ( click the link to review the publication )

Drug Metab Dispos, 2021, 49(1):53-61

PubMed: 33148688 ( click the link to review the publication )

Nat Commun, 2021, 12(1):808

PubMed: 33547292 ( click the link to review the publication )

Dev Biol, 2021, 473:80-89

PubMed: 33577829 ( click the link to review the publication )

Mol Cell, 2020, 80(6):1104-1122.e9

PubMed: 33259812 ( click the link to review the publication )

Clin Cancer Res, 2020, 20 pii: clincanres

PubMed: 32312893 ( click the link to review the publication )

Genome Med, 2020, 18;12(1):17

PubMed: 32070411 ( click the link to review the publication )

Biomaterials, 2020, 237:119793

PubMed: 32044521 ( click the link to review the publication )

Cancers (Basel), 2020, 12(11)E3172

PubMed: 33126775 ( click the link to review the publication )

Br J Cancer, 2020, 22

PubMed: 32439932 ( click the link to review the publication )

Front Cell Dev Biol, 2020, 8:578

PubMed: 32733887 ( click the link to review the publication )

Aging (Albany NY), 2020, 7;12(9):8221-8240

PubMed: 32379705 ( click the link to review the publication )

Aging (Albany NY), 2020, 13(1):1096-1119

PubMed: 33291075 ( click the link to review the publication )

Cancer Cell Int, 2020, 19;20:58

PubMed: 32099531 ( click the link to review the publication )

Toxicol In Vitro, 2020, 71:105063

PubMed: 33271325 ( click the link to review the publication )

Molecules, 2020, 26(1)E35

PubMed: 33374788 ( click the link to review the publication )

Burns Trauma, 2020, 8:tkaa025

PubMed: 33150188 ( click the link to review the publication )

Hum Cell, 2020, 10.1007/s13577-020-00420-z

PubMed: 32870449 ( click the link to review the publication )

Hum Cell, 2020, 10.1007/s13577-020-00425-8

PubMed: 32886306 ( click the link to review the publication )

Cell Rep, 2020, 32(2):107906

PubMed: 32668247 ( click the link to review the publication )

Exp Ther Med, 2020, 19(2):1336-1342

PubMed: 32010307 ( click the link to review the publication )
J Cell Mol Med, 2020, 24(4):2402-2415

PubMed: 31957261 ( click the link to review the publication )

Neoplasia, 2020, 22(10):470-483

PubMed: 32818841 ( click the link to review the publication )

Dev Cell, 2019, 48(2):151-166.e7

PubMed: 30639056 ( click the link to review the publication )

Proc Natl Acad Sci U S A, 2019, 116(25):12353-12362

PubMed: 31152134 ( click the link to review the publication )

ACS Appl Mater Interfaces, 2019, 101021/acsami9b20178

PubMed: 31816241 ( click the link to review the publication )

Cell Rep, 2019, 28(9):2331-2344

PubMed: 31461650 ( click the link to review the publication )

Int J Cancer, 2019, 145(7):1991-2001

PubMed: 30848481 ( click the link to review the publication )

Lab Chip, 2019, 19(12):2071-2080

PubMed: 31049508 ( click the link to review the publication )

J Exp Clin Cancer Res, 2019, 38(1):322

PubMed: 31331377 ( click the link to review the publication )

Mol Cancer Ther, 2019, 10.1158/1535-7163.MCT-18-1319

PubMed: 31594826 ( click the link to review the publication )

Hum Mol Genet, 2019, 10.1093/hmg/ddz152

PubMed: 31518391 ( click the link to review the publication )

Pharmacol Res, 2019, 144:292-305

PubMed: 31048033 ( click the link to review the publication )

J Immunol, 2019, 203(10):2630-2643

PubMed: 31586036 ( click the link to review the publication )

J Cell Physiol, 2019, 10.1002/jcp.28810

PubMed: 31093976 ( click the link to review the publication )

Int J Nanomedicine, 2019, 14:441-455

PubMed: 30666106 ( click the link to review the publication )

J Cell Mol Med, 2019, 23(2):920-933

PubMed: 30394679 ( click the link to review the publication )

Plast Reconstr Surg, 2019, 143(1):126-135

PubMed: 30303928 ( click the link to review the publication )

Naunyn Schmiedebergs Arch Pharmacol, 2019, 10.1007/s00210-019-01746-8

PubMed: 31655854 ( click the link to review the publication )

Commun Biol, 2019, 2:170

PubMed: 31098403 ( click the link to review the publication )

Cancer Immunol Res, 2019, 7(9):1523-1534

PubMed: 31266784 ( click the link to review the publication )

Assay Drug Dev Technol, 2019, 17(4):167-177

PubMed: 31184962 ( click the link to review the publication )

Nat Commun, 2018, 9(1):5009

PubMed: 30479336 ( click the link to review the publication )

Cell Death Dis, 2018, 9(10):974

PubMed: 30250188 ( click the link to review the publication )

Mol Cancer Ther, 2018, 17(7):1405-1415

PubMed: 29695637 ( click the link to review the publication )
J Cell Physiol, 2018, 233(3):2067-2074

PubMed: 28294324 ( click the link to review the publication )

Am J Physiol Cell Physiol, 2018, 314(5):C589-C602

PubMed: 29351406 ( click the link to review the publication )

Cell Biol Int, 2018, 42(11):1511-1522

PubMed: 30080297 ( click the link to review the publication )

Biomed Chromatogr, 2018, 32(6):e4184

PubMed: 29283445 ( click the link to review the publication )

Oncol Lett, 2018, 15(5):6107-6114

PubMed: 29731842 ( click the link to review the publication )

Oncotarget, 2018, 9(89):35962-35973

PubMed: 30542510 ( click the link to review the publication )

Proc Natl Acad Sci U S A, 2017, 114(11):2934-2939

PubMed: 28246332 ( click the link to review the publication )

Cancer Res, 2017, 77(5):1212-1226

PubMed: 28087600 ( click the link to review the publication )

Theranostics, 2017, 7(16):3972-3988

PubMed: 29109792 ( click the link to review the publication )

Oncogene, 2017, 10.1038/onc.2017.132

PubMed: 28481872 ( click the link to review the publication )

Br J Cancer, 2017, 117(5):e3

PubMed: 28704838 ( click the link to review the publication )

Arch Toxicol, 2017, 91(8):2921-2938

PubMed: 28032146 ( click the link to review the publication )

Cell Chem Biol, 2017, 24(7):858-869

PubMed: 28669525 ( click the link to review the publication )

Hum Mol Genet, 2017, 26(22):4375-4387

PubMed: 28973155 ( click the link to review the publication )

Front Oncol, 2017, 7:182

PubMed: 28879167 ( click the link to review the publication )

Cell Biosci, 2017, 7:43

PubMed: 28852468 ( click the link to review the publication )

Eur Radiol, 2017, 27(3):918-926

PubMed: 27287476 ( click the link to review the publication )

Chem Biodivers, 2017, 14(3)

PubMed: 27936296 ( click the link to review the publication )

Oncotarget, 2017, 9(5):5529-5544

PubMed: 29464016 ( click the link to review the publication )

Neural Regen Res, 2017, 12(11):1816-1822

PubMed: 29239327 ( click the link to review the publication )

Nat Commun, 2016, 7:11363

PubMed: 27193833 ( click the link to review the publication )

Clin Cancer Res, 2016, 22(8):1940-50

PubMed: 26578684 ( click the link to review the publication )

Proc Natl Acad Sci U S A, 2016, 113(33):9339-44

PubMed: 27482107 ( click the link to review the publication )

Cancer Res, 2016, 76(11):3200-10

PubMed: 27197162 ( click the link to review the publication )
Cancer Res, 2016, 76(1):117-26

PubMed: 26677977 ( click the link to review the publication )

PLoS Genet, 2016, 12(9):e1006279

PubMed: 27588951 ( click the link to review the publication )

J Immunol, 2016, 197(2):504-16

PubMed: 27279371 ( click the link to review the publication )

Sci Rep, 2016, 6:24453

PubMed: 27076230 ( click the link to review the publication )

CNS Neurosci Ther, 2016, 22(6):440-50

PubMed: 26861512 ( click the link to review the publication )

Cellular Signalling, 2016, 19;28(6):652-662

PubMed: 27006333 ( click the link to review the publication )

Oncotarget, 2016, 7(18-:25983-6002

PubMed: 27036020 ( click the link to review the publication )

Mol Nutr Food Res, 2015, 59(11):2255-66

PubMed: 26255647 ( click the link to review the publication )

PLoS One, 2015, 10(10):e0140310

PubMed: 26461489 ( click the link to review the publication )

PLoS One, 2015, 10(6):e0128897

PubMed: 26042424 ( click the link to review the publication )

Anal Chem, 2014, 86(17):8842-9

PubMed: 25118958 ( click the link to review the publication )

J Cell Biochem, 2014, 10.1002/jcb.25066

PubMed: 25536282 ( click the link to review the publication )

Drug Des Devel Ther, 2014, 8:1107-23

PubMed: 25170251 ( click the link to review the publication )

PLoS One, 2014, 9(1):e85759

PubMed: 24454929 ( click the link to review the publication )

Gene Expression Patterns , 2014, 16(2):93-103

PubMed: 25460514 ( click the link to review the publication )

Oncotarget, 2014, 5(16):6801-15

PubMed: 25149535 ( click the link to review the publication )

J Nucl Med, 2013, 54(9):1630-6

PubMed: 23907757 ( click the link to review the publication )

Sci Signal, 2013, 6(271):ra25

PubMed: 23592840 ( click the link to review the publication )

Br J Cancer, 2013, 110(4):894-8

PubMed: 24398510 ( click the link to review the publication )

Development, 2013, 140(20):4214-25

PubMed: 24026121 ( click the link to review the publication )

Acta Oncol, 2013, 53(5):637-45

PubMed: 24041258 ( click the link to review the publication )

Histochem Cell Biol, 2013, 139(3):431-45

PubMed: 23052841 ( click the link to review the publication )

J Labelled Comp Radiopharm, 2013, 56(2):42-9

PubMed: 24285281 ( click the link to review the publication )

Glia, 2012, 60(6):936-47

PubMed: 22431192 ( click the link to review the publication )
Cancer Sci, 2012, 103(3):433-8

PubMed: 22098620 ( click the link to review the publication )

Mol Med, 2012, 18:887-98

PubMed: 22549112 ( click the link to review the publication )

Cells Tissues Organs, 2012, 196(3):195-205

PubMed: 22433970 ( click the link to review the publication )

J Biomol Screen, 2011, 16(2):141-54

PubMed: 21297102 ( click the link to review the publication )

Purity & Quality Control

Choose Selective VEGFR Inhibitors

Biological Activity

Description

Features

Superior as second-line therapy relative to sorafenib (current standard-of-care).

Targets

VEGFR1/FLT1 ^[1] (Porcine aorta endothelial cells)	VEGFR2/Flk1 ^[1] (Porcine aorta endothelial cells)	VEGFR2/KDR ^[1] (Porcine aorta endothelial cells)	VEGFR3 ^[1] (Porcine aorta endothelial cells)	PDGFRβ ^[1] (Porcine aorta endothelial cells)	View More
0.1 nM	0.18 nM	0.2 nM	0.1 nM-0.3 nM	1.6 nM	View More

In vitro

Axitinib could block the cellular autophosphorylation of VEGFR and VEGF-mediated endothelial cell viability, tube formation, and downstream signaling. Axitinib inhibits the proliferation of variable cell lines with IC50 of >10,000 nM (IGR-N91), 849 nM (IGR-NB8), 274 nM (SH-SY5Y) and 573 nM (non-VEGF stimulated HUVEC). ^[2]

Cell Data

Cell Lines	Assay Type	Incubation Time	Activity Description	PMID
EoL-1-cell	M3;aSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MlvGTWM2OD1yLkCwNFA2OTNizszN	M4DCXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
NCI-H1703	M174dGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M4PUPGlEPTB;MD6wNFA6ODJizszN	NIfCd\|A9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
KASUMI-1	NWXvfFJKT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MoPmTWM2OD1yLkCwOlgzKM7:TR?=	NIroeXI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
CGTH-W-1	MmnCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MWHJR\|UxRTBwMEC3NlIh\|ryP	NVz5TIU4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
A204	M{T1U2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M4rnS2lEPTB;MD6wNFk6OiEQvF2=	NIPjOoU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
HOP-62	MnW2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		Ml[5TWM2OD1yLkGwPFM3KM7:TR?=	NIPi[pY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
H-EMC-SS	NYDwWZNST3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M2HQNWlEPTB;MD6xNVAxPSEQvF2=	M2PkVlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
KU812	M2XPZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NGXDNnJKSzVyPUCuNVY2PzdizszN	MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
EM-2	NEPPdmJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NGP3V4xKSzVyPUCuNVY5OTZizszN	Mn;5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
LAMA-84	MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NInlW2pKSzVyPUCuNVc3PjVizszN	MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
JAR	NHrRUHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NHq2eXZKSzVyPUCuNlM6QDlizszN	NXfCeFEzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
G-361	NI\YfGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NF33O3VKSzVyPUCuN\|I{OjVizszN	M1yzXlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
KG-1	M2qxUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M{TLZWlEPTB;MD6zO\|Y1OiEQvF2=	NEXZZmQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
BV-173	Ml\1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NES5fYpKSzVyPUCuN\|k{OiEQvF2=	MkTxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
K5	NHPGb2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MUXJR\|UxRTBwNEKxNlch\|ryP	NEnGd5Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
MEG-01	M17Xc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NGnUNJpKSzVyPUCuOFI{PjFizszN	MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
MFM-223	NGr0fY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M1PjTWlEPTB;MD60OFc4PiEQvF2=	MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
BE-13	MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NHqz[GZKSzVyPUCuOVExODhizszN	MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
NEC8	M4TLWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NFvxe21KSzVyPUCuO\|IyOTNizszN	NXPhS5IzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
SW756	MnTHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M{fUdmlEPTB;MD65PVg1PiEQvF2=	NH3PXoI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
A2780	NHHqNpVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NFzKWo9KSzVyPUGuNFEyPDZizszN	MnHDQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
NB14	M3fwPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MUPJR\|UxRTFwMEG4NFEh\|ryP	Mk\0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
H4	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MUnJR\|UxRTFwME[0NlIh\|ryP	MlLKQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
SK-OV-3	NVrueZU5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MYHJR\|UxRTFwME[2N\|Mh\|ryP	NHzDU5g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
AN3-CA	NG\RXmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MXrJR\|UxRTFwMEizPFkh\|ryP	MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
A427	NYPRXId4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NEHIcXlKSzVyPUGuNVA{QDFizszN	M3rNSlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
ES7	NEm4TmlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NEnDV3hKSzVyPUGuNVE{OzRizszN	M{fMe\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
AGS	M3HMVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NITu[ZpKSzVyPUGuNVE{QTVizszN	NXHNb412RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
G-402	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NYrzW4NMUUN3ME2xMlE1Pjl2IN88US=>	NETz[GU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
ES5	MlPKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MYjJR\|UxRTFwMUeyOFgh\|ryP	M4TTbFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
DEL	MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MWnJR\|UxRTFwMkW0OVch\|ryP	M1O0d\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
NB10	NULUVG1qT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M4Xx[GlEPTB;MT6zNlU2PyEQvF2=	NYrWSG81RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
NCI-H1581	Ml7oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NFrNfJRKSzVyPUGuN\|kxPDJizszN	M13MVVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
D-566MG	MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MXjJR\|UxRTFwNEC2PFMh\|ryP	NVLvdJJFRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
LXF-289	NF\ZeI5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M17pXGlEPTB;MT60N\|k6PiEQvF2=	MnT5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
BT-549	MmfqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MYHJR\|UxRTFwNU[5NFkh\|ryP	MlTvQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
NKM-1	MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MUnJR\|UxRTFwNkC1OVYh\|ryP	NVHxS\|RKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
SW780	NITuVY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NIHGPZdKSzVyPUGuOlUyPThizszN	NVTmS\|lvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
NCI-H292	MmqwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MnXHTWM2OD1zLk[2N\|g{KM7:TR?=	NUPCbnZVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
HMV-II	M4n0Omdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NVG2clhJUUN3ME2xMlcxPDh6IN88US=>	MnHLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
ALL-PO	NX6yXoZIT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M4HXTmlEPTB;MT64NFAyPSEQvF2=	MnrHQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
UACC-257	NEfZTGRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M{TPV2lEPTB;MT64NlE3OyEQvF2=	NWjqTFR7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
PA-1	M2G4Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MVHJR\|UxRTFwOEK3NlUh\|ryP	NGLLT2c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
HD-MY-Z	NWrHNWYxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MkD0TWM2OD1zLki2NlgyKM7:TR?=	NXLBSJZERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
HSC-4	M3jJSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MVrJR\|UxRTFwOUO4N\|kh\|ryP	MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
GCT	MonIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NGLrT5RKSzVyPUKuNFA6OTZizszN	M13pfVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
RT-112	MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MV;JR\|UxRTJwMUO0NlQh\|ryP	NFj6WGM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
A172	NGfOO2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MW\JR\|UxRTJwMUO2NFYh\|ryP	MleyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
HCE-T	M4C5c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MnnPTWM2OD1{LkKwOVk5KM7:TR?=	NWDCRmJ7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
YH-13	NV7USIxIT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NYf1coxYUUN3ME2yMlIyPjdzIN88US=>	M4f1NlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
DK-MG	NVHKUWRYT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NXnaZndqUUN3ME2yMlI{QDN2IN88US=>	NXnsOIJiRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
ACN	MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NGHyZppKSzVyPUKuNlM5PzVizszN	NEHXVG49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
VA-ES-BJ	NXrOSW9[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NUTy[GpFUUN3ME2yMlI1QTV5IN88US=>	M1XLUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
L-363	M131TGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NEXrPI5KSzVyPUKuNlgxPjFizszN	NFHwR4c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
HuH-7	MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NVzUSm5sUUN3ME2yMlQzOTZ3IN88US=>	MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
A4-Fuk	NUPpelhVT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MXzJR\|UxRTJwNEexOlgh\|ryP	NHXvPII9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
T-24	NWrz[m9yT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NXfPOnZmUUN3ME2yMlQ5ODN5IN88US=>	NHTNOpg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
GOTO	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M2\ufWlEPTB;Mj61N\|AyOyEQvF2=	MlrlQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
MV-4-11	MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NITPbHRKSzVyPUKuOVkyPjlizszN	NVywPGxzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
DMS-114	M3XtPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		Moi0TWM2OD1{Lk[2N\|Q2KM7:TR?=	MlnQQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
MHH-NB-11	M2rNe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NV;P[4RwUUN3ME2yMlcxOjl7IN88US=>	MXq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
CHP-212	NY\vRpo2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NWX4Opo3UUN3ME2yMlgzODlzIN88US=>	Ml\OQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
DMS-273	M3LafWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		Mn3ETWM2OD1{LkmwNlA4KM7:TR?=	M1XZd\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
SF295	Ml3JS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MnTvTWM2OD1\|LkCyOVk4KM7:TR?=	NVzwUFJURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
NCI-H1563	NXjNWYZWT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NVLqXol4UUN3ME2zMlE2ODB3IN88US=>	NYjRfWVNRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
NCI-H446	MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MY\JR\|UxRTNwMkK4NFUh\|ryP	M{fFS\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
HCC1806	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NYDjb\|FyUUN3ME2zMlI4PjV5IN88US=>	MYi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
SF126	MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NWLlOFNDUUN3ME2zMlMxODF5IN88US=>	M2j0clxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
SW982	NX21e\|ZLT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MXjJR\|UxRTNwM{O4O\|Uh\|ryP	MnzkQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
ES8	MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NVTEOWUyUUN3ME2zMlM1QTl7IN88US=>	NWrmbYVORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
SCC-4	MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NVTu[ldOUUN3ME2zMlUxOzl4IN88US=>	NYPU[Wo6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
RPMI-8226	MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MXrJR\|UxRTNwNkK2NVYh\|ryP	MmrOQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
EW-11	MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NU\pe2dpUUN3ME2zMlY{ODJ{IN88US=>	NFTUWlM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
COR-L105	M2P3NGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		Mo\pTWM2OD1\|Lk[zN\|M1KM7:TR?=	MkHyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
ES1	NWLQd4ppT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MXzJR\|UxRTNwOEOwPVQh\|ryP	NVPhO4lCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
KMOE-2	M2XrT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MoLHTWM2OD1\|LkmxPFA5KM7:TR?=	MmfaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
ABC-1	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M2m1PGlEPTB;Mz65N\|kyOSEQvF2=	MmPXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
NCI-H526	NY\iVJBlT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MYDJR\|UxRTNwOUmxNlYh\|ryP	NEf5NnM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
HCC1395	MnPwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NX3scItvUUN3ME2zMlk6PDh2IN88US=>	M3vZcVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
DU-145	NXzhNVA{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NXPwVoxOUUN3ME20MlEzQDJ3IN88US=>	M37VbVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
JEG-3	MnO4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M3vIRWlEPTB;ND6xOVkyPiEQvF2=	M3vjXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
HCC1187	MofZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MX\JR\|UxRTRwMkG1PVch\|ryP	MofmQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
LC-2-ad	NGPCeWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MofqTWM2OD12LkKyNVc4KM7:TR?=	MnvhQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
ONS-76	MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MoDTTWM2OD12LkK0NVkzKM7:TR?=	M1GzZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
CAL-27	NH3KbHJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NHOyeHlKSzVyPUSuNlQ{PDRizszN	NYLSZY9lRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
8-MG-BA	NGPWZlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MXvJR\|UxRTRwMk[2OVgh\|ryP	MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
HGC-27	MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NYrjPIN3UUN3ME20MlI6PjZizszN	NXjFOXpuRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
Hs-578-T	M3r3UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MnHtTWM2OD12LkOxOFY5KM7:TR?=	NFm4dno9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
EW-1	NF\oV\|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NG[wO4JKSzVyPUSuOVMxOTRizszN	NGHDfW49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
SW1573	NX7GcVJuT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M3LRU2lEPTB;ND61OVE3OyEQvF2=	NVvJSVdyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
SNU-423	NHHmT45Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NIHxdlNKSzVyPUSuOlA4QSEQvF2=	MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
HOS	NGTJSJhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MWXJR\|UxRTRwNkm3O{DPxE1?	NVqzd3lERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
LB1047-RCC	NEW3U41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MmnhTWM2OD12LkixOFE5KM7:TR?=	MV68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
ChaGo-K-1	NETSS3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M1\KV2lEPTB;ND64PVA1QCEQvF2=	Mn3pQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
A3-KAW	MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NF3iPGxKSzVyPUSuPVc{PTJizszN	MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
CAS-1	M2XsNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NFiyW\|RKSzVyPUSuPVk6ODhizszN	NFjiPGU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
NBsusSR	Ml7RS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M1nuTGlEPTB;NT6wN\|UyPCEQvF2=	M4LiZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
KM12	NI\VbW5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NYL5XYdUUUN3ME21MlI6QDJ5IN88US=>	MlXrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
NCI-H1155	NYKzfmVxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NV3tN4NMUUN3ME21MlM5OTh3IN88US=>	NY\4R\|dyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
EFM-19	NH7IRYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NXPTT4hnUUN3ME21MlQyPzN5IN88US=>	MojlQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
D-392MG	NFrHUZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M1K3d2lEPTB;NT61O\|g1QSEQvF2=	NYrKeIQxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
JVM-3	NUjrZmZwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NI\FSoZKSzVyPUWuO\|I{OjVizszN	M4fDNFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
EW-16	NVrId2RST3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MUjJR\|UxRTVwN{W1PFMh\|ryP	Mn7VQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
KARPAS-45	MmXqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MlHoTWM2OD13Lki0N\|I2KM7:TR?=	NYLwT\|llRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
NCI-H28	Mk\sS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MoL5TWM2OD13Lki3PVE5KM7:TR?=	NHOwd\|A9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
COLO-829	Mn;rS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		Mn;6TWM2OD13LkmxOVA1KM7:TR?=	MYi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
KM-H2	MojGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M{i2eWlEPTB;NT65NlM6PSEQvF2=	M160TVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
NCI-H82	M1j0T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MoTmTWM2OD13LkmyO\|cyKM7:TR?=	NIH6O5Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
OAW-42	MmL4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		Ml;vTWM2OD13Lkm4PFIyKM7:TR?=	MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
A704	NEL3XHpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NIfpWHNKSzVyPU[uNVA2PzRizszN	MkjWQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
NCI-H1048	MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M{WyfGlEPTB;Nj6xNFU6QSEQvF2=	MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
LOXIMVI	M4X4ZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M4K1[mlEPTB;Nj6xNVI1QCEQvF2=	NXXHR2JHRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
MKN45	Ml;mS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MmLRTWM2OD14LkK2NFE3KM7:TR?=	NXGxRXoxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
D-502MG	MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NEDae\|dKSzVyPU[uNlg5PTdizszN	NFXKcmY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
HUTU-80	NWO3SJU1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MYTJR\|UxRTZwNEG2PFgh\|ryP	M2\HZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
S-117	M4r4UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MXnJR\|UxRTZwNUCyOlch\|ryP	NV7k[4N6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
HCC1569	MnO0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NXnCVJN7UUN3ME22MlU{PzN5IN88US=>	NXHPO2lTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
J-RT3-T3-5	MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MmrDTWM2OD14LkW0OVczKM7:TR?=	NFLnV4Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
OC-314	MmewS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MWHJR\|UxRTZwOUGxOVkh\|ryP	M2nsRVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
SNU-449	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MoSwTWM2OD15LkCxNFczKM7:TR?=	NXPwc5NLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
NCI-H720	NV;B[JVZT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NXXMfWh3UUN3ME23MlE6OzR3IN88US=>	MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
KP-N-YS	MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		Mof6TWM2OD15LkKwO\|Ih\|ryP	MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
IGROV-1	Mk\6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MVzJR\|UxRTdwM{KzPFYh\|ryP	NYLQT5VWRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
SK-PN-DW	MnuwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NIfGcpZKSzVyPUeuOFgyPSEQvF2=	MoHRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
HCC1419	NF\ER2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MlPkTWM2OD15LkWzJO69VQ>?	M3G0S\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
HAL-01	MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M1OyXWlEPTB;Nz62NFY1PCEQvF2=	NYLiN3B7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
HCC2998	M2Ptc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MUTJR\|UxRTdwNkC3OFMh\|ryP	MlrRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
SK-N-FI	MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M{PpT2lEPTB;Nz62N\|A{OyEQvF2=	NIT5OFI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
GI-ME-N	MmjtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NWP0SYhjUUN3ME23MlY1QTN2IN88US=>	NVjZ[5g5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
SW1088	NE\XNZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NYTSUHc6UUN3ME23MlY2QDJ4IN88US=>	NWfoTW96RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
IA-LM	M13kc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MWTJR\|UxRTdwNki2NVMh\|ryP	M2roVFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
SK-NEP-1	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MUnJR\|UxRTdwNkm2NUDPxE1?	M2DTUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
MDA-MB-415	MlXaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MYXJR\|UxRTdwOEmxPFYh\|ryP	NUG5SndKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
COLO-800	M2XQVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NH36Zm5KSzVyPUeuPVQ1QTJizszN	MmjQQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
NCI-H2228	NV7wNmEzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NX7QNlR6UUN3ME24MlE2Pzh\|IN88US=>	M3LVZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
D-423MG	MlP3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MUjJR\|UxRThwMkG3NkDPxE1?	MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
TE-1	NWfZfXZMT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		Mmn4TWM2OD16LkS0N\|E3KM7:TR?=	MlSyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
NOS-1	NUnCVWRjT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MVjJR\|UxRThwNUG1N\|Qh\|ryP	NIfRSHg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
8505C	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M2W1PGlEPTB;OD62OFgzPCEQvF2=	NYXlXHB3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
HEC-1	MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MofLTWM2OD16Lke4OFM6KM7:TR?=	NITSS\|g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
TE-11	M123V2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NYDZUnFWUUN3ME24Mlk6PTVzIN88US=>	NVnPN492RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
CTB-1	MkC0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MVTJR\|UxRTlwMEG0N\|Mh\|ryP	NEHER5E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
TGBC11TKB	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MXLJR\|UxRTlwMEKyOFEh\|ryP	M4fPfFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
NB17	Ml\zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M1TI[2lEPTB;OT6xPFg4KM7:TR?=	NVH5W3A2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
Becker	MofuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NEmySmpKSzVyPUmuOFE6PDRizszN	NV3Qfo55RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
SN12C	NIPuZZFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NF\tc\|ZKSzVyPUmuOFUzOzRizszN	NIHlc3Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
COLO-320-HSR	NGLMTGhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NYjOVItuUUN3ME25MlYxOjN5IN88US=>	M4HEeFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
D-283MED	MnjTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NVnncZFwUUN3ME25MlY{ODd{IN88US=>	MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
D-263MG	MkLpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M3znTWlEPTB;OT64N\|M5PCEQvF2=	NEXqPYw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
MEL-JUSO	Ml;CS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NIrKNYVKSzVyPUmuPVAyOjdizszN	M3y4UFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
T98G	MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MV7JR\|UxRTlwOUCyNFMh\|ryP	M3viT\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
HLE	M2T3NGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M2\mV2lEPTB;OT65NFkxQSEQvF2=	NH76S3o9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
Ca9-22	NWPnS4twT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NVyyRYNbUUN3ME2xNE4xPjZ3IN88US=>	NUHHUGhuRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
OS-RC-2	M{XYbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NVi3XIhsUUN3ME2xNE4yODR3IN88US=>	MVG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
T47D	M2rm[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NUTSN4JXUUN3ME2xNE4yPTVizszN	NWrWW4FmRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
GI-1	Ml3oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NVTLTXNFUUN3ME2xNE4{PTN\|IN88US=>	MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
NUGC-3	NYnSOWFJT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MkHJTWM2OD1zMD60OFAzKM7:TR?=	MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
MDA-MB-361	MmjKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M2DobWlEPTB;MUCuOFQ{OiEQvF2=	MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
SCC-15	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NFnVdm9KSzVyPUGwMlQ4OThizszN	NVHzc3dKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
KS-1	M1[yPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MV;JR\|UxRTFyLk[zNFEh\|ryP	MmW4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
CAL-12T	NVHOOlRJT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MoDqTWM2OD1zMD62N\|YyKM7:TR?=	NF7jd209[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
OVCAR-4	M4W2S2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M1K2XGlEPTB;MUCuO\|A3QCEQvF2=	NUXXfIUzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
HuP-T4	MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MVHJR\|UxRTFzLkCzNlgh\|ryP	M1S1fFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
NCI-H358	NGCybm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MkXaTWM2OD1zMT6yOlU4KM7:TR?=	NF:1XIQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
HO-1-N-1	MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M2fTfmlEPTB;MUGuN\|M6QCEQvF2=	MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
NH-12	M1vxOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NVXhcYdnUUN3ME2xNU42Ozd6IN88US=>	MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
MOLT-4	M2TOUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M1SwUWlEPTB;MUGuOVk5PSEQvF2=	NELTVIo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
K-562	NGHJd4dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MU\JR\|UxRTFzLkeyOFgh\|ryP	MoXyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
ES6	MmXMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MmewTWM2OD1zMT64OVgyKM7:TR?=	MoPPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
RO82-W-1	M2jteGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M3LSPWlEPTB;MUGuPVA3PCEQvF2=	Mn:5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
Ramos-2G6-4C10	M{m1UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NHvPPYJKSzVyPUGxMlk{OiEQvF2=	MYe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
23132-87	NVz6[WxxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M2\FSWlEPTB;MUKuNFgzOSEQvF2=	Ml;0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
A549	MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MYLJR\|UxRTF{LkOyPFUh\|ryP	MlzDQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
NCI-H23	M3TnSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NVPqOIxjUUN3ME2xNk42ODJ4IN88US=>	MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
H9	MlfIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NIHoXnNKSzVyPUGyMlU2PzdizszN	NH;LW289[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
LB771-HNC	MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M2DqbGlEPTB;MUKuO\|Y2KM7:TR?=	NYrOSGNoRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
QIMR-WIL	NV2yV3YzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MXvJR\|UxRTF{LkiyOVgh\|ryP	Mm\VQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
HSC-3	NUfrTolUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NG\BSIRKSzVyPUGyMlkzPzZizszN	M3LiW\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
PFSK-1	M3HnVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MX\JR\|UxRTF{Lkm1NFch\|ryP	NHTJ[mE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
ETK-1	M3;Ubmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MXjJR\|UxRTF\|LkC3O\|kh\|ryP	M1[wZ\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
SW1710	NEnZNFFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NETw[WtKSzVyPUGzMlM3PDFizszN	Ml7JQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
COLO-684	NIrpfWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MlL1TWM2OD1zMz60OVQyKM7:TR?=	M3zrT\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
RPMI-7951	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NWPUUVBWUUN3ME2xN{42OTN4IN88US=>	Mme3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
A101D	NXTtcI15T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M4nsUmlEPTB;MUOuOVM1QSEQvF2=	NX7P[2k4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
KE-37	NVX0b21LT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MVrJR\|UxRTF\|LkW4PFch\|ryP	MonYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
SiHa	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MVPJR\|UxRTF\|LkizOFYh\|ryP	NH3D[Gg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
NCI-H226	NH32OpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NVmwTXk4UUN3ME2xN{45QDB6IN88US=>	MVe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
DB	NGnPZm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NX7HNHV3UUN3ME2xN{46QTJ6IN88US=>	NUnpV3JtRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
HT-1197	NIXT[49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MW\JR\|UxRTF2LkC4NFkh\|ryP	MnvOQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
SBC-5	NHiwdYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NXHBdIlLUUN3ME2xOE4yOzZ{IN88US=>	NYryeWFLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
VMRC-RCZ	M{mxW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		Mk\wTWM2OD1zND61O\|c1KM7:TR?=	MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
697	MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M{LGOWlEPTB;MUSuOlI4KM7:TR?=	M3rNUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
OMC-1	NF3xN2JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MmDPTWM2OD1zND63PFg5KM7:TR?=	NEHGNW89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
SKG-IIIa	NY\SVVAxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NF;OUoRKSzVyPUG0MlgxODFizszN	NXOxUG0xRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
DOK	NY[yXZJlT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NGP1fVNKSzVyPUG0Mlk6OzNizszN	NIrJSHo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
NCI-H2029	MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MVnJR\|UxRTF3LkO2NFIh\|ryP	MUe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
NCI-H2009	M2rrbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NWHYZ5VrUUN3ME2xOU42ODl3IN88US=>	MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
LK-2	M4jLcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MWDJR\|UxRTF3Lk[0OFkh\|ryP	M1XwWVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
NCI-H661	MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NXvzToJvUUN3ME2xOU46ODd3IN88US=>	M1nHcFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
GT3TKB	NX\0eXJRT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NVuyVYpMUUN3ME2xOk4xPjd4IN88US=>	M1;NNlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
GP5d	M2jFRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M4nn[WlEPTB;MU[uN\|QzKM7:TR?=	NX7JO5FZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
SK-MEL-2	NIHVfWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		Ml;FTWM2OD1zNj60OFg2KM7:TR?=	MWC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
SK-UT-1	NHnTSlRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NFuzT2lKSzVyPUG2MlU3PSEQvF2=	Mn;0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
NB7	NILQZYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MknETWM2OD1zNj62PVcyKM7:TR?=	NGLQZ2s9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
NCI-H460	NEHtdm1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MXzJR\|UxRTF4LkezNlYh\|ryP	M4rZXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
8305C	NXTlU4FWT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NXTY[IxbUUN3ME2xOk44QDd5IN88US=>	NEnmc3E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
CaR-1	NF;GcWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MVvJR\|UxRTF4LkixNVEh\|ryP	NETp[lY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
D-247MG	NHr4RlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MXXJR\|UxRTF4Lki2NlUh\|ryP	M1G1U\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
LoVo	MkPSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MkDZTWM2OD1zNj65OFg5KM7:TR?=	M{\0RlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
NCI-H2405	MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NYTobINZUUN3ME2xO{4yQTB6IN88US=>	M2HFc\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
AU565	MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M{PuUWlEPTB;MUeuNlI2KM7:TR?=	Mk\pQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
OCI-AML2	Mn\GS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M4fNN2lEPTB;MUeuOVMyPyEQvF2=	Ml7zQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
22RV1	M{nOTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M1rQVGlEPTB;MUeuOVg5PCEQvF2=	NInBSFM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
HT-144	NEnVN2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MlzYTWM2OD1zNz62OVk5KM7:TR?=	NVK3S4txRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
HuO9	M3Pkcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M{HvZ2lEPTB;MUeuO\|A{OSEQvF2=	MkTrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
Daoy	MmLsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M2r1OmlEPTB;MUeuO\|E5PCEQvF2=	NWfUSJJmRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
SJRH30	M4m2Nmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NXLTUHpCUUN3ME2xO{45PDh7IN88US=>	MoPYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
CHL-1	MoTPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NYLOO\|BGUUN3ME2xO{46OjR7IN88US=>	MX68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
J82	M4LIcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		Mnr4TWM2OD1zNz65OlM2KM7:TR?=	NGjDVYo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
COR-L23	NXn2R3RlT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NXrqdGlbUUN3ME2xPE4xODFzIN88US=>	NYfXbWZ[RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
SNU-C2B	M2izOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M1vQNmlEPTB;MUiuNlI4PiEQvF2=	MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
NCI-H1770	NFHQNlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M3:3cWlEPTB;MUiuOFYyPSEQvF2=	NFOwW3o9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
MHH-PREB-1	MmWyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M1\mOGlEPTB;MUiuOVY6PyEQvF2=	M1XhcFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
ES3	MkPoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NILPbopKSzVyPUG4MlU5QDNizszN	NFy5fo89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
MDA-MB-231	M17EfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MkjGTWM2OD1zOD62OVAzKM7:TR?=	NHrpcGs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
MN-60	NFXxVGZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NYDYU\|VHUUN3ME2xPU4xPTl{IN88US=>	NIXTcGo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
EPLC-272H	M1nsTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NFHGUVRKSzVyPUG5MlM4ODhizszN	NF7Jbpc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
SW948	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M3;ac2lEPTB;MUmuN\|k{PCEQvF2=	M3X5fFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
MOLT-13	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NF;z[mdKSzVyPUG5MlQ2PDZizszN	MmTCQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
HL-60	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MX3JR\|UxRTJyLkKxOFEh\|ryP	MlG3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
CP50-MEL-B	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NVTaRXJlUUN3ME2yNE41PzR6IN88US=>	MUe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
NTERA-S-cl-D1	NHnxbFZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MmLUTWM2OD1{MD60PVc5KM7:TR?=	NHnlfow9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
KINGS-1	NX73dFBsT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NUjmSZFDUUN3ME2yNE44QTZ5IN88US=>	Mlr6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
DOHH-2	NUT2NohHT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M4TicGlEPTB;MkCuPVA3KM7:TR?=	M13tXlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
BB65-RCC	MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MoDZTWM2OD1{MD65Nlg2KM7:TR?=	MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
NB12	M3LQ[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MnnzTWM2OD1{MT6wN\|k1KM7:TR?=	NF;aUFQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
KY821	M3nHb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M4K1c2lEPTB;MkGuOVgzKM7:TR?=	M{nrZ\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
PSN1	NXnqfYN4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NIHlNmZKSzVyPUKxMlY1PTNizszN	MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
EGI-1	M2j3[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MorCTWM2OD1{MT63OFU1KM7:TR?=	MmPNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
CTV-1	M3;IWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MVzJR\|UxRTJ{LkOwN\|Eh\|ryP	MoToQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
TI-73	NF;VdGNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M3PXc2lEPTB;MkKuN\|Q6QCEQvF2=	NYX0OnQxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
LCLC-103H	M1LIVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MWTJR\|UxRTJ{LkS3OVIh\|ryP	MnftQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
D-542MG	NEG2endIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NYLzcGFSUUN3ME2yNk42PTV6IN88US=>	M1XjXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
ATN-1	NUPTZmFET3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NYnaTZhNUUN3ME2yNk43PDN7IN88US=>	M4\Ve\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
SK-MEL-1	Mly1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M4DKNmlEPTB;MkKuPFM3QCEQvF2=	MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
HDLM-2	NFe4UXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MYTJR\|UxRTJ\|LkG0O\|gh\|ryP	NWC4V3llRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
UM-UC-3	M1;5UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NG\qTVBKSzVyPUKzMlE6PDRizszN	NFnEPIM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
NCI-H1573	NFLlclVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NH3POoxKSzVyPUKzMlQ3QDFizszN	MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
NCI-H520	MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NGfFdlJKSzVyPUKzMlQ6PDhizszN	MkPVQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
ESS-1	Mnv2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MWjJR\|UxRTJ\|LkiwOVkh\|ryP	MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
COR-L88	MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MnfVTWM2OD1{Mz65OFc2KM7:TR?=	M2D2[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
TGBC24TKB	NXrpXW9{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M1[wd2lEPTB;MkSuNFMyOiEQvF2=	M{WzXFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
HCC1937	MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NIrIW5BKSzVyPUK0MlEh\|ryP	MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
RS4-11	NUGzdYd1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NXTSTVFnUUN3ME2yOE4yPDJizszN	NXXzdVRDRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
HCC38	MnrVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NFjD[IRKSzVyPUK0MlI{QTRizszN	MXm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
RPMI-2650	M2Pid2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MVPJR\|UxRTJ2Lk[xOlIh\|ryP	M2rsNlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
P12-ICHIKAWA	MmS4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M33mS2lEPTB;MkSuOlI2QCEQvF2=	Mnn6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
YAPC	MofES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NGXpeFFKSzVyPUK0MlgzOTRizszN	NYntfmlbRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
NB13	NW\mWo04T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NGLl[mRKSzVyPUK1MlI3OTFizszN	M2rlN\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
SK-N-AS	NXnPelJUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NX31RnB1UUN3ME2yOU45PTh2IN88US=>	NXLjT5JORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
SK-N-DZ	M37wSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MXLJR\|UxRTJ4LkC0PUDPxE1?	NYPpSXdlRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
LS-411N	NVHme3BIT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MoDvTWM2OD1{Nj6yNFM5KM7:TR?=	NHqxOWw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
NCI-H810	MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MlWxTWM2OD1{Nj6zNVEzKM7:TR?=	MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
NCI-SNU-1	M37hb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MX7JR\|UxRTJ4LkW0OVQh\|ryP	MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
HH	NXzLUI9CT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NXLnSpVrUUN3ME2yOk42PTJ7IN88US=>	NFXkTI09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
U-2-OS	NUnhOGFTT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NGfPflVKSzVyPUK2Mlc{QDJizszN	M4PlNVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
SF539	NGHOOVZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NUXWPVVUUUN3ME2yOk45ODF6IN88US=>	Mo[5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
NCI-H2052	M4r3S2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NFXvOpdKSzVyPUK3MlA5PiEQvF2=	MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
A673	NHvBeZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M2PBNmlEPTB;MkeuNlExOiEQvF2=	NX32WWxvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
WM-115	Mnq2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MXjJR\|UxRTJ5Lke3Olch\|ryP	MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
SW48	NXnIWYU{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MlnCTWM2OD1{Nz64NFA2KM7:TR?=	MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
NOMO-1	NV24O\|BTT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NWPzU2VoUUN3ME2yO{45PTN{IN88US=>	MnPlQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
PC-3	NXK4e4V6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NXewUW4{UUN3ME2yO{45QTRzIN88US=>	M{fE[\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
UMC-11	NFfQcYNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NFnrN2VKSzVyPUK3Mlk{PDNizszN	NG[3XlQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
U-118-MG	MmTxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NXj0V5ZIUUN3ME2yPE4xOTJ\|IN88US=>	MkDNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
NCI-H2452	M3e1U2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		Mmm4TWM2OD1{OD6wPFIzKM7:TR?=	NXPTenRjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
CAMA-1	NX;PWlNiT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MXvJR\|UxRTJ6Lki1OlQh\|ryP	NGjsdlE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
MC-IXC	NUnoXo9rT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M{LobmlEPTB;MkmuNlM3PiEQvF2=	M3;yXFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
ES4	M4XjeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MYrJR\|UxRTJ7LkOxO\|Ih\|ryP	MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
BHT-101	NELV[XJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NFu5PHBKSzVyPUK5MlMzOSEQvF2=	NFPUXHA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
KP-4	M3nIe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NVLJU2xjUUN3ME2yPU42OTZizszN	NF;HdFU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
CAL-54	M3rIcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MX\JR\|UxRTJ7LkW0OFUh\|ryP	MoewQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
5637	MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NIHVZoFKSzVyPUK5MlY1OjFizszN	NFL1Wmw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
MOLT-16	MkHxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NXTl[491UUN3ME2yPU44OjZ7IN88US=>	MmLuQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
Ca-Ski	M37tOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		Mn7GTWM2OD1{OT65OFYh\|ryP	M3fSSlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
AsPC-1	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M3;CVGlEPTB;M{CuNFIyOiEQvF2=	NVezR4ljRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
MSTO-211H	Mnm5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		Mmm5TWM2OD1\|MD6xOUDPxE1?	Mkm5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
L-428	NEnkS21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MlnVTWM2OD1\|MD60NFUh\|ryP	NHPD[lQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
SW1463	NWXqWIpwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MlzoTWM2OD1\|MD61N\|g{KM7:TR?=	NGnkWnA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
NCI-H1648	NFWyTXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MWDJR\|UxRTNyLkW1O\|Qh\|ryP	M4HaZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
CAKI-1	NV3JXFF{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MWLJR\|UxRTNyLke3NFIh\|ryP	MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
YKG-1	M3n3PWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		Mme1TWM2OD1\|MT6wNlY{KM7:TR?=	MnjKQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
A2058	M33aPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M3;TZmlEPTB;M{GuNVE3PCEQvF2=	M{jobFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
A375	MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NEDiRVlKSzVyPUOxMlE3QTZizszN	NFj1ZVA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
SNB75	NYjLeVlsT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NFvvdmRKSzVyPUOxMlI1OzVizszN	NG\0O3M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
SK-HEP-1	M{O0Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M13qV2lEPTB;M{GuOFI4OSEQvF2=	NXLFO5FRRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
ME-180	NVzMPXJ1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NFzFSHFKSzVyPUOxMlY2PDJizszN	NWmydWdjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
NCI-H209	Mme2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MYDJR\|UxRTNzLkiyOFch\|ryP	NE\QVoo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
HC-1	MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NWLhcWU6UUN3ME2zNk4yPDR4IN88US=>	MlrMQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
LB373-MEL-D	NH3jO29Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NHPWNo5KSzVyPUOyMlE6PzFizszN	NWnOcoZ3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
SNU-387	MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MnjITWM2OD1\|Mj6zNVkyKM7:TR?=	MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
C32	NHLHfphIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M4TuWWlEPTB;M{KuN\|M2OyEQvF2=	MmqzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
EW-13	M3PUOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M{DMPWlEPTB;M{KuPVQxQCEQvF2=	MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
BFTC-905	MlXSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		Mnv5TWM2OD1\|Mz61NVM3KM7:TR?=	MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
NCI-H1299	M{nGSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NUTpVXVGUUN3ME2zN{42PjJzIN88US=>	NWXBdoZkRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
LU-135	NXLsNGhkT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M17tN2lEPTB;M{OuPFAyKM7:TR?=	M4jwXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
NCI-H2122	NV25TVhDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MlnvTWM2OD1\|Mz65PVY3KM7:TR?=	MoC1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
SK-LMS-1	Ml;iS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NVrwRo5bUUN3ME2zOE41OTB5IN88US=>	Mki5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
LNCaP-Clone-FGC	NYC1UZpDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MX3JR\|UxRTN2Lki1NVUh\|ryP	MoP5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
NCI-H1092	NWrReodVT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M{DqWWlEPTB;M{WuNlc1PyEQvF2=	NFLLVIo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
MS-1	NVLqcY06T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MXfJR\|UxRTN3LkOwN\|gh\|ryP	MnL0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
KYSE-510	Mn\QS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NUXZUJBVUUN3ME2zOU42ODR{IN88US=>	MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
NCI-H1793	NIXCSZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NWTXZnFPUUN3ME2zOU43PTR3IN88US=>	NE\hOJY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
MIA-PaCa-2	NIHMRWpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MXTJR\|UxRTN4LkC0PVYh\|ryP	NEn1OnQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
EW-22	NWfmZ\|N2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MlnaTWM2OD1\|Nj60NFczKM7:TR?=	MXm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
IGR-1	M3HSSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		Mn2zTWM2OD1\|Nj64NVg1KM7:TR?=	NV\rRnI3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
HT-1080	M3LmcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NH\iSm9KSzVyPUO3MlEzPSEQvF2=	NYTQb4Z2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
M14	M{OySmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MkHzTWM2OD1\|Nz6xOlQzKM7:TR?=	Mn\rQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
786-0	MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NYnPZnpSUUN3ME2zO{4zPzl2IN88US=>	MmnLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
MZ2-MEL	NVPQXVJMT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MX;JR\|UxRTN5LkS1NFEh\|ryP	M2LKflxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
NCI-H510A	NHjoXIRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NXH3[mptUUN3ME2zO{46PDF{IN88US=>	NEPncnk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
LAN-6	NYjVRmg{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MorRTWM2OD1\|Nz65OVgzKM7:TR?=	MlHXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
SW620	NFHkPZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NYfq[483UUN3ME2zPE41QTd2IN88US=>	NWDnTnRZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
LB2241-RCC	NEDmeXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NX3yXWNYUUN3ME2zPU45OjB3IN88US=>	MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
Detroit562	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NGTKS2NKSzVyPUSwMlEzPjhizszN	NGXLd3Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
HN	MoPsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NIfFTItKSzVyPUSwMlE4QDJizszN	MmLnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
HCT-15	MoL0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MX\JR\|UxRTRyLkW5NFch\|ryP	NXXpUYVLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
C2BBe1	NWr2XmJFT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NX62Z2F7UUN3ME20NE46OTV5IN88US=>	MnvMQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
A498	NHznc4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M{XMbmlEPTB;NEGuN\|AyPSEQvF2=	NGn4[Wk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,W0GQR1XSQE9iRg>?
SK-MEL-24	MlLkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NWXTVmEyUUN3ME20NU41PzJ3IN88US=>	MYW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
OVCAR-5	M3fYPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M4fVUGlEPTB;NEGuO\|c3PyEQvF2=	NYj0PYlERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
NCI-H1792	NELicZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NGXIPZRKSzVyPUSxMlk5OjFizszN	NXnoUJMxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
KOSC-2	MmrQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NFqzZYtKSzVyPUSyMlI3QTlizszN	MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
Mo-T	M1vMS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MVTJR\|UxRTR{Lki5OVgh\|ryP	Ml\VQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
CFPAC-1	M3Xlemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NXjaNY9tUUN3ME20N{41QTR2IN88US=>	MnrwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
CAL-51	NWPnWlRKT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M3PFRWlEPTB;NEOuOVYxPSEQvF2=	MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
RH-18	Mnz6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NIfLfW9KSzVyPUSzMlgxPSEQvF2=	NYHTU3dSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
EC-GI-10	MmnqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MlnRTWM2OD12Mz64N\|Q4KM7:TR?=	MojSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
HSC-2	Ml\0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M4PvSWlEPTB;NESuNFA6KM7:TR?=	MkO5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
ML-2	NXTtdXdCT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NETEPJlKSzVyPUS1MlI3OjFizszN	NXrhOHlPRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
KNS-81-FD	NX73XWhwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M{jrS2lEPTB;NEWuO\|M3PSEQvF2=	NWjJW4hwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
NB6	M3;BOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NXrqUmtpUUN3ME20Ok4yOTFizszN	MoqzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
MCF7	M{\obmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NHfncYRKSzVyPUS2MlU2OzNizszN	MVW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
P30-OHK	MoDNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NVrSdHpZUUN3ME20Ok45OTF5IN88US=>	NU[0RnFFRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
BPH-1	MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		Mn[5TWM2OD12Nj65PFA2KM7:TR?=	NVL5cnlVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
U251	NHLoSZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M3jFbGlEPTB;NE[uPVk1KM7:TR?=	M1KwTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
MKN1	MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NGnKXGdKSzVyPUS3MlUyOzdizszN	NVjwVGl3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
A431	NEfob2JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NWPHTVlIUUN3ME20O{45OzN6IN88US=>	M4nSRVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFEzQDl7Mk[vK\|5USU6JRWK8M4E,
C8166	NGHtOHpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NGjFZ2tKSzVyPUS5MlIxOzlizszN	NUHIb454RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
HEL	NX\jSZllT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M4HB[GlEPTB;NEmuOFA3PCEQvF2=	MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+V2FPT0WUPD;hQi=>
RMG-I	NIe2VIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NGS5VZFKSzVyPUS5MlQ1PDRizszN	Mn;VQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
CAL-72	NVjjdHp6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NHTmZmRKSzVyPUS5MlYxPzVizszN	NVHxVGRHRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTJ6OUmyOk8oRlODTlfFVlww[T5?
SW962	NXvRdFVPT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M4\qZmlEPTB;NEmuPVM{OiEQvF2=	MlrYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQnNCVkeHUkyvZV4>
MCF7	M{TxOWFvfGmycn;sbYZmemG2aY\lJIF{e2G7	MmDKOUBl[Xm\|	M2PmRmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTVPGO{Bk\WyuczDhd5Nme3OnZDDhd{Boem:5dHigbY5pcWKrdHnvckBi\nSncjC1JIRigXNiYomgV3JDKGG\|c3H5MEBIUTVyIE2gNE46PyEQvF2u	NETjPFk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{iyPVU1QSd-MkO4Nlk2PDl:L3G+
MDA-MB-468	NGCxWmdCdnSrcILvcIln\XKjdHn2[UBie3OjeR?=	NFTXW5o2KGSjeYO=	MnHJRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCPRFGtUWIuPDZ6IHPlcIx{KGG\|c3Xzd4VlKGG\|IHfyc5d1cCCrbnjpZol1cW:wIHHmeIVzKDViZHH5d{BjgSCVUlKgZZN{[XluIFfJOVAhRSBzLkOg{txONg>?	MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzh{OUW0PUc,OjN6Mkm1OFk9N2F-
HCC1954	NXTiNJBPSW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=	NW\GZnNbPSCmYYnz	MlHXRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCKQ1OxPVU1KGOnbHzzJIF{e2W\|c3XkJIF{KGe{b4f0bEBqdmirYnn0bY9vKGGodHXyJFUh\GG7czDifUBUWkJiYYPzZZktKEeLNUCgQUAzNjdizszNMi=>	MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzh{OUW0PUc,OjN6Mkm1OFk9N2F-
SKBR3	NVPuVXV1SW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=	MWq1JIRigXN?	NFLsfHVCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGPLRnI{KGOnbHzzJIF{e2W\|c3XkJIF{KGe{b4f0bEBqdmirYnn0bY9vKGGodHXyJFUh\GG7czDifUBUWkJiYYPzZZktKEeLNUCgQUA{NjhizszNMi=>	MnPlQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN6Mkm1OFkoRjJ\|OEK5OVQ6RC:jPh?=
MDA-MB-231	MUTBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>?	MVm1JIRigXN?	NITyeWhCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3ERU1OSi1{M{GgZ4VtdHNiYYPz[ZN{\WRiYYOg[5Jwf3SqIHnubIljcXSrb36gZYZ1\XJiNTDkZZl{KGK7IGPSRkBie3OjeTygS2k2OCB;IEeuN{DPxE1w	M3XKTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ\|OEK5OVQ6Lz5{M{iyPVU1QTxxYU6=
MCF7	NWTBZW9uS3m2b4TvfIlkcXS7IHHzd4F6	NEHY[4g2KGSjeYO=	NGnmeHlEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBOS0Z5IHPlcIx{KGGodHXyJFUh\GG7czDifUBUWkJiYYPzZZktKEeLNUCgQUAzNjNizszNMi=>	Mn;yQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR6Nke0NFMoRjJ2OE[3OFA{RC:jPh?=
MDA-MB-468	NUXkT3NWS3m2b4TvfIlkcXS7IHHzd4F6	NVTTcoJkPSCmYYnz	MVXDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDNSGEuVUJvNE[4JINmdGy\|IHHmeIVzKDViZHH5d{BjgSCVUlKgZZN{[XluIFfJOVAhRSB{Lkig{txONg>?	NYnsb5hPRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS4Olc1ODNpPkK0PFY4PDB\|PD;hQi=>
SKBR3	MmX3R5l1d3SxeHnjbZR6KGG\|c3H5	NFLPcXo2KGSjeYO=	M1:4fGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHNMSlJ\|IHPlcIx{KGGodHXyJFUh\GG7czDifUBUWkJiYYPzZZktKEeLNUCgQUA1NjZizszNMi=>	NFLnS5Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEi2O\|QxOyd-MkS4Olc1ODN:L3G+
MDA-MB-231	MnnJR5l1d3SxeHnjbZR6KGG\|c3H5	Ml\oOUBl[Xm\|	MmD1R5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUWRCNU2ELUKzNUBk\WyuczDh[pRmeiB3IHThfZMh[nliU2LCJIF{e2G7LDDHTVUxKD1iMUGg{txONg>?	NH3UXoo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEi2O\|QxOyd-MkS4Olc1ODN:L3G+
Saos-2	NWXHUo9keUiWUzDhd5NigQ>?		M1jQUJFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCVYX;zMVIh[2WubIO=	NUHxZ294RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N\|UyOzlpPkK5OFM2OTN7PD;hQi=>
BT-12	NET4PYFyUFSVIHHzd4F6		MVvxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW\|IH\vdkBlenWpIILldJVzeG:\|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhSlRvMUKgZ4VtdHN?	MlXsQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN\|koRjJ7NEO1NVM6RC:jPh?=
OHS-50	MV;xTHRUKGG\|c3H5		MlLidWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[\|ohWHKrbXHyfUB{[3KnZX6g[o9zKE:KUz21NEBk\Wyucx?=	MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR\|NUGzPUc,Ojl2M{WxN\|k9N2F-
SJ-GBM2	NUTJZolYeUiWUzDhd5NigQ>?		NWT4WFV1eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC\|Y4Ll[Y4h\m:{IGPKMWdDVTJiY3XscJM>	MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR\|NUGzPUc,Ojl2M{WxN\|k9N2F-
SK-N-MC	NYDPd\|dMeUiWUzDhd5NigQ>?		NXHNc3lreUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC\|Y4Ll[Y4h\m:{IGPLMW4uVUNiY3XscJM>	NYLHPGpiRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N\|UyOzlpPkK5OFM2OTN7PD;hQi=>
NB-EBc1	NVnGT3V4eUiWUzDhd5NigQ>?		NWraSmZveUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC\|Y4Ll[Y4h\m:{IF7CMWVD[zFiY3XscJM>	NVfD[\|hmRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N\|UyOzlpPkK5OFM2OTN7PD;hQi=>
Rh18	M16xc5FJXFNiYYPzZZk>		MWfxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW\|IH\vdkBlenWpIILldJVzeG:\|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhWmhzODDj[Yxtew>?	M2\lcFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
HUVEC	NEHiS2ZCdnSrcILvcIln\XKjdHn2[UBie3OjeR?=	MmrmNUBpeg>?	MnvzRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDWSWdHNXO2aX31cIF1\WRiSGXWSWMh[2WubIOgZZN{\XO\|ZXSgZZMhemWmdXP0bY9vKGmwIHPlcIwhfmmjYnnsbZR6KHC{ZXnuZ5Vj[XSnZDDmc5IhOSCqcjDmc4xtd3enZDDifUBi\GSrdHnvckBw\iCYRVfGJI1m[XO3cnXkJIFnfGW{IEeyJIhzeyCkeTDNWHQh[XO\|YYmsJGlEPTBiPTCwMlAxODVizszNMi=>	MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+R4hGVUKOPD;hQi=>
HUVEC	M1fHSmFvfGmycn;sbYZmemG2aY\lJIF{e2G7	MoTVNUBpeg>?	MkDwRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDWSWdHNXO2aX31cIF1\WRiSGXWSWMh[2WubIOgZZN{\XO\|ZXSgZZMhemWmdXP0bY9vKGmwIHPlcIwhfmmjYnnsbZR6KHC{ZXnuZ5Vj[XSnZDDmc5IhOSCqcjDmc4xtd3enZDDifUBi\GSrdHnvckBw\iCYRVfGJI1m[XO3cnXkJIFnfGW{IEeyJIhzeyCrbjDwdoV{\W6lZTDv[kBidGK3bXnuJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDBwMECyO{DPxE1w	NGrXZYY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyOjh7OUK2M{c,S2iHTVLMQE9iRg>?
A549	MlztRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl?	NUTnR5BKPDhiaILz	M2PpdmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgWmVITi2\|dHnteYxifGWmIHj1cYFvKEF3NEmgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KEOFS{igZZN{[XluIFnDOVAhRSB{Mj60JO69VS5?	MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxNlg6QTJ4Lze+R4hGVUKOPD;hQi=>
HepG2	M4fvNGFvfGmycn;sbYZmemG2aY\lJIF{e2G7	NF3wdZc1QCCqcoO=	M1;zfGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgWmVITi2\|dHnteYxifGWmIHj1cYFvKEincFeyJINmdGy\|IHHmeIVzKDR6IHjyd{BjgSCFQ1u4JIF{e2G7LDDJR\|UxKD1iM{iuO{DPxE1w	MkDOQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVI5QTl{Nj:nQmNpTU2ETEyvZV4>

... Click to View More Cell Line Experimental Data

Assay

Methods	Test Index	PMID
Western blot	p-c-kit / c-kit / p-AKT / AKT / p-ERK / ERK / p-STAT3 / STAT3 / p-STAT5 / STAT5 / p-S6K / S6K / p-S6 / S6; PubMed: 31205508 Ther Adv Med Oncol Immunoblotting analysis of indicated proteins in c-KIT mediated signaling pathways of GIST-T1, GIST-882, GIST-48B, and GIST-5R cell lines. PARP / cleaved PARP / caspase-3 / cleaved caspase-3; PubMed: 31205508 Ther Adv Med Oncol Immunoblotting analysis of apoptosis-related proteins after axitinib treatment in human GIST cell lines. Imatinib and sunitinib were used as positive controls.	31205508
Immunofluorescence	alpha-tubulin; PubMed: 26474283 Oncotarget Representative images of RCC cells treated as above described, and then immunostained with anti-α-tubulin antibody. Bar: 50 μM	26474283
Growth inhibition assay	Cell viability ; PubMed: 26474283 Oncotarget A. A-498 and Caki-2 RCC cell lines were cultured up to 96 h with different doses of axitinib. Cell viability was determined by MTT assay. Data shown are expressed as mean ± SD of three separate experiments; *p < 0.01 vs vehicle-treated cells. B. RCC cell 䲧疝Ỵ疞㧀疜膉痘 瘿삨ՂᾰƌՂĀ 㺣痖帉痖Ѐ瑖堘𢡄빢᎒ՂĀ鑸᎒彿堙奋堙巫堙᎒ﻺ᎒彿堙ﻮ᎒塚堙ﻺ᎒ꍈ堞빢᎒學堙漸堞圔堙빢᎒圞堙圭堙𢡄玚Wᾰƌ ᾰƌ戤瘯Ɖ⟸෕䐺痖暼瘿⟸෕ᾰƌ ⟸෕Ð㺣痖⟸෕	26474283

In vivo

Axitinib exhibits primary inhibition to orthotopically transplanted models such as M24met (melanoma), HCT-116 (colorectal cancer), and SN12C (renal cell carcinoma). ^[1] Axitinib delays the tumor growth with 11.4 days compared to the controls (p.o. 30 mg/kg) and decreases the Mean Vessels Density (MVD) to 21, compared to 49 in controls, in IGR-N91 ﬂank xenografts. ^[2] Axitinib significantly inhibits growth and disrupts tumor microvasculature in BT474 breast cancer model at 10-100 mg/kg. ^[3] Axitinib has shown single-agent activity in variable tumors, including renal cell carcinoma, thyroid cancer, non-small cell lung cancer, and melanoma.

Protocol

Kinase Assay: ^[1]	- Collapse Cellular receptor kinase phosphorylation assay: Porcine aorta endothelial (PAE) cells, which overexpress full-length VEGFR2, PDGFRβ, Kit, and NIH-3T3, which overexpress murine VEGFR2 (Flk-1) or PDGFRα, are generated. The 96-well plates are coated with 100 μL/well of 2.5 μg/mL anti-VEGFR2 antibody, 0.75 μg/mL anti-PDGFRβ antibody, 0.25 μg/mL anti-PDGFRα antibody, 0.5 μg/mL anti-KIT antibody, or 1.20 μg/mL anti-Flk-1 antibody to prepare ELISA capture plates. Then phosphorylation of RTK is measured by ELISA.
Cell Research: ^[2]	- Collapse Cell lines: HUVEC, SH-SY5Y, IGR-N91 and IGR-NB8 cells Concentrations: 1 nM - 10 μM Incubation Time: 72 hours Method: Cells are seeded in a 96-well plate at a density of 5 × 10⁴ and cultured for 24 hours. Axitinib is added to the cells at concentrations ranging from 1 nM to 10 μM. Cell viability is measured after 72 hours by MTS tetrazolium substrate and IC50 values are calculated. (Only for Reference)
Animal Research: ^[3]	- Collapse Animal Models: BT474 breast cancer cells are implanted subcutaneously into Immune-deficient female mice (Nu/nu; age 8-12 weeks). Dosages: 10, 30 or 100 mg/kg Administration: Oral daily (Only for Reference)

References

- Collapse

Solubility (25°C)

In vitro	DMSO	35 mg/mL warmed (90.56 mM)
	Water	Insoluble
	Ethanol	Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information Download Axitinib SDF

Molecular Weight	386.47
Formula	C₂₂H₁₈N₄OS
CAS No.	319460-85-0
Storage	3 years-20°C powder 2 years-80°C in solvent
Synonyms	AG 013736
Smiles	CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

Dosage

mg/kg

Average weight of animals

Dosing volume per animal

Number of animals

Step 2: Enter the in vivo formulation (Different batches have different solubility ratios, please contact Selleck to provide you with the correct ratio)

% DMSO+ % + % Tween 80+ % ddH₂O

Calculate Reset

Calculation results:

Working concentration： mg/ml；

Method for preparing DMSO master liquid: ： mg drug pre-dissolved in μL DMSO (Master liquid concentration mg/mL， Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation：Take μL DMSO master liquid, next addμL PEG300， mix and clarify, next addμL Tween 80，mix and clarify, next add μL ddH₂O，mix and clarify.

Note：1.Please make sure the liquid is clear before adding the next solvent.
2.Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.

Bio Calculators

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration _(start) x Volume _(start) = Concentration _(final) x Volume _(final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

Serial Dilutions
Concertration (start):
Dilution-folds:

Computed Result

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Clinical Trial Information (data from https://clinicaltrials.gov, updated on 2021-01-06)

NCT Number	Recruitment	interventions	Conditions	Sponsor/Collaborators	Start Date	Phases
NCT04682587	Not yet recruiting	Drug: Axitinib\|Drug: Avelumab\|Drug: Pembrolizumab	Renal Cell Carcinoma	Pfizer	December 21 2020	--
NCT04669366	Not yet recruiting	Drug: sunitinib\|Drug: axitinib	Kidney Neoplasms	Pfizer	December 15 2020	--
NCT04626128	Recruiting	Drug: CLS-AX\|Drug: Anti-VEGF	Neovascular Age-related Macular Degeneration	Clearside Biomedical Inc.	December 15 2020	Phase 1\|Phase 2
NCT04637204	Recruiting	Drug: Cabozantinib\|Drug: Axitinib	Renal Cell Carcinoma	Ipsen	November 24 2020	--
NCT04555603	Active not recruiting	Drug: Inlyta\|Drug: Bavencio\|Drug: Keytruda	Renal Cell Carcinoma	Pfizer	September 15 2020	--
NCT04522323	Recruiting	Biological: MEDI5752\|Drug: Axitinib	Advanced Renal Cell Carcinoma	MedImmune LLC	August 5 2020	Phase 1

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Frequently Asked Questions

Question 1:
We would like to store at -80℃ after it dissolved in CMC. Do you have any infomation about the suggested concentration in CMC?
Answer:
Axitinib in 0.5% CMC at up to 30mg/ml is a suspension for oral gavage administration only. We don't suggest customer to freeze down the solution but to make fresh if possible. Customer can store it for 1-2 weeks at 4 degree for continuous use.

VEGFR Signaling Pathway Map

VEGFR Inhibitors with Unique Features

Selective VEGFR Inhibitors

Vandetanib (ZD6474) : VEGFR2-selective, IC50=40 nM.
Most Potent VEGFR Inhibitor

Cabozantinib (XL184, BMS-907351) : VEGFR2, IC50=0.035 nM.
FDA-approved VEGFR Inhibitor

Regorafenib (BAY 73-4506) : Approved by FDA for metastatic colorectal cancer and advanced gastrointestinal stromal tumors.
Classic VEGFR Inhibitor

Nintedanib (BIBF 1120) : Potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50 of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM. Phase 3.

Related VEGFR Products

SU5402 ^New

SU5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 nM, 30 nM, and 510 nM for VEGFR2, FGFR1, and PDGF-Rβ, respectively.
Erlotinib ^New

Erlotinib (CP358774, NSC 718781, OSI-774) is an EGFR inhibitor with IC50 of 2 nM, >1000-fold more sensitive for EGFR than human c-Src or v-Abl. Erlotinib induces autophagy.
Bemcentinib (R428) ^New

Bemcentinib (R428, BGB324) is an inhibitor of Axl with IC50 of 14 nM, >100-fold selective for Axl versus Abl. Selectivty for Axl is also greater than Mer and Tyro3 (50-to-100- fold more selective) and InsR, EGFR, HER2, and PDGFRβ (100- fold more selective).
Regorafenib (BAY 73-4506)

Regorafenib (BAY 73-4506, Fluoro-Sorafenib, Resihance, Stivarga) is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFRβ, Kit (c-Kit), RET (c-RET) and Raf-1 with IC50 of 13 nM/4.2 nM/46 nM, 22 nM, 7 nM, 1.5 nM and 2.5 nM in cell-free assays, respectively. Regorafenib induces autophagy.
Cabozantinib (BMS-907351)

Cabozantinib (XL184, BMS-907351) is a potent VEGFR2 inhibitor with IC50 of 0.035 nM and also inhibits c-Met, Ret, Kit, Flt-1/3/4, Tie2, and AXL with IC50 of 1.3 nM, 4 nM, 4.6 nM, 12 nM/11.3 nM/6 nM, 14.3 nM and 7 nM in cell-free assays, respectively. Cabozantinib induces PUMA-dependent apoptosis in colon cancer cells via AKT/GSK-3β/NF-κB signaling pathway.
Nintedanib (BIBF 1120)

Nintedanib (BIBF 1120, Intedanib, Vargatef, Ofev) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50 of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM in cell-free assays. Phase 3.
Vandetanib (ZD6474)

Vandetanib (ZD6474) is a potent inhibitor of VEGFR2 with IC50 of 40 nM in a cell-free assay. It also inhibits VEGFR3 and EGFR with IC50 of 110 nM and 500 nM, respectively. Not sensitive to PDGFRβ, Flt1, Tie-2 and FGFR1 with IC50 of 1.1-3.6 μM. No activity against MEK, CDK2, c-Kit, erbB2, FAK, PDK1, Akt and IGF-1R with IC50 above 10 μM. Vandetanib (ZD6474) increases apoptosis and induces autophagy by increasing the level of reactive oxygen species (ROS).
Lenvatinib (E7080)

Lenvatinib (E7080) is a multi-target inhibitor, mostly for VEGFR2(KDR)/VEGFR3(Flt-4) with IC50 of 4 nM/5.2 nM, less potent against VEGFR1/Flt-1, ~10-fold more selective for VEGFR2/3 against FGFR1, PDGFRα/β in cell-free assays. Lenvatinib (E7080) also inhibits FGFR1-4, PDGFR, Kit (c-Kit), RET (c-RET), and shows potent antitumor activities. Phase 3.
Pazopanib

Pazopanib (GW786034) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms/CSF1R with IC50 of 10 nM, 30 nM, 47 nM, 84 nM, 74 nM, 140 nM and 146 nM in cell-free assays, respectively. Pazopanib induces cathepsin B activation and autophagy.
Pazopanib HCl (GW786034 HCl)

Pazopanib HCl (GW786034 HCl) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms with IC50 of 10 nM, 30 nM, 47 nM, 84 nM, 74 nM, 140 nM and 146 nM in cell-free assays, respectively. Pazopanib induces autophagic Type II cell death.

Features:A multi-kinase inhibitor.

Choose Your Country or Region

By Signaling Pathways

By product type

Axitinib